Sort   by:  
 Page size 
UnknownEstablished and Emerging Treatments of Skin GvHD.
Not available
S-EPMC8847139 | biostudies-literature
UnknownMyelodysplastic Syndromes and Metabolism.
Not available
S-EPMC8541058 | biostudies-literature
UnknownLong-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms.
Not available
S-EPMC8688843 | biostudies-literature
UnknownClonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden.
Not available
S-EPMC4740451 | biostudies-literature
UnknownMDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.
Not available
S-EPMC10844065 | biostudies-literature
UnknownDeep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears.
Not available
S-EPMC8727290 | biostudies-literature
UnknownPrevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Not available
S-EPMC8941459 | biostudies-literature
UnknownAzacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation.
Not available
S-EPMC3763388 | biostudies-literature
UnknownThe diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
Not available
S-EPMC8714728 | biostudies-literature
UnknownComprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.
Not available
S-EPMC11417473 | biostudies-literature
Sort   by:  
 Page size